THE Food and Drug Administration (FDA) has given a "compassionate special permit" to a hospital to use the anti-parasitic drug Ivermectin against the coronavirus disease 2019 (Covid-19).
This comes despite repeated warnings from health experts that the drug had "little to no effect" on patients with Covid-19, with the World Health Organization prohibiting its use outside of clinical trials.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.